LoadingLoadingLoading35 funds hold it.Insiders net selling.
Net selling: insiders sold $2.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: both buying and selling, $2K to $30K in total in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 4, 2026
Financial period
Fiscal 2027 Second Quarter
Earnings per share
$10.75 expected
Revenue
$109.95B expected
Estimates as of Nov 10, 2026
EPS expected
$10.41 to $11.71
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 4, 2026 | $11.68est. $10.75 | +8.62%beat | $110.96Best. $109.95B+0.91% | +7.6%from $103.15B |
| Jun 30, 2026Reported Aug 5, 2026 | $9.93est. $9.54 | +4.14%beat | $105.38Best. $103.74B+1.58% | +7.7%from $97.83B |
| Mar 31, 2026Reported May 7, 2026 | $11.69est. $11.57 | +1.06%beat | $96.30BCompany release | +6.0%from $90.82B |
| Dec 31, 2025Reported Feb 4, 2026 | $9.34est. $9.27 | +0.71%in line | $106.16BSEC filing | +11.4%from $95.29B |
| Sep 30, 2025Reported Nov 5, 2025 | $9.86est. $8.92 | +10.54%beat | $103.15BSEC filing | +10.1%from $93.65B |
| Jun 30, 2025Reported Aug 6, 2025 | $8.26est. $8.15 | +1.35%beat | $97.83BSEC filing | +23.4%from $79.28B |
| Mar 31, 2025Reported May 8, 2025 | $10.12est. $9.83 | +2.95%beat | $90.82BAlpha Vantage | +18.9%from $76.36B |
| Dec 31, 2024Reported Feb 5, 2025 | $8.03est. $7.99 | +0.50%in line | $95.29BSEC filing | +17.8%from $80.90B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $106.16B | $96.30B | $105.38B | $110.96B |
| Cost of what it sold | $102.47B | $92.25B | $101.69B | $107.00B |
| Gross profit | $3.69B | $4.04B | $3.69B | $3.96B |
| What it spent | ||||
| Sales and admin | $2.03B | $1.80B | $2.26B | $2.27B |
| Other operating costs | $36.0M | — | $102.0M | $83.0M |
| Total operating expenses | $2.07B | $1.80B | $2.37B | $2.35B |
| What was left | ||||
| Operating profit | $1.62B | $2.25B | $1.32B | $1.60B |
| Interest on debt | $63.0M | $61.0M | $77.0M | $105.0M |
| Profit before tax | $1.63B | $2.13B | $1.31B | $1.56B |
| Tax | $380.0M | $270.0M | $276.0M | $266.0M |
| Net profit | $1.19B | $1.68B | $614.0M | $1.22B |
| EBITDA | $1.84B | $2.26B | $1.58B | $1.86B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
BullishNov 9DataMEDS Completes First Compounded Peptide Sale
Leans bullishNov 9CorMedix Therapeutics to Acquire Substantially All Assets
NeutralNov 9Weekly Recap: Albumin revenue falls and Canadian collections restart
Leans bearishNov 9Cardinal Health (CAH) Lifts Guidance As Investors Ask If The Story Is Fully Valued
NeutralNov 7McKesson Q2 Earnings Call Highlights
BullishNov 7Form 4 McKesson: Francisco Fraga (EVP, CIO and CTO) For: 5 November
NeutralNov 6Form 4 MCKESSON CORP For: Nov 05 Filed by: Fraga Francisco
Leans bearishNov 6
